Various studies have demonstrated the safety and efficacy of recombinant human thyroid-stimulating hormone (rhTSH) for radioiodine remnant ablation. On this basis, rhTSH was approved in Europe for the radioiodine ablation of low-risk differentiated thyroid cancer (DTC) during thyroid hormone therapy with L-thyroxine (L-T4). Moreover, in December 2007, the US Federal Drug Administration approved...

BACKGROUND Skeletal metastases in oncology patients are identified by Bone scan and/Positron Emission Tomography (PET) scan. But developing countries in the world still lack adequate numbers of these imaging facilities. AIMS Since Magnetic Resonance Imaging (MRI) is widely available as compared to bone scan or PET scan; a double blind study was undertaken to see if whole body imaging with MRI...

We describe a patient with newly diagnosed limy cancer. Staging was performed with CT and mediastinoscopy. FDG PET scan was performed and confirmed increased metabolic activity in the primary tumor as well as the hilar lymph node. Seven months after initial presentation, the patient was found to have two lytic lesions in the pelvis on plain radiograph. Hone scan was negative but PET demon...

this report presents a 3.5-year-old boy who was hospitalized for limping. medical history and physical exams were not suggestive for any definitive diagnosis. laboratory and radiographic exams did not support any specific diagnosis either. subsequently bone scan was performed and increased activity in the ankle due to cuboid fracture was incidentally observed.

BACKGROUND The aim of this paper is to present our experience concerning cooperation in the treatment of Slovak patients with differentiated thyroid cancer in Slovak and Czech hospitals. The objectives of this study were to demonstrate the means of this cooperation and the results of therapy. MATERIAL AND METHODS From September 1991 to October 2005 in the Department of Nuclear Medicine in Ost...

Aim: There is a need to evaluate the treatment response in patients who have undergone radioiodine (RIT) for differentiated thyroid cancer. Diagnostic tests that are used this purpose include whole-body scan (WBS) and serum thyroglobulin (Tg) measurement, which most accurate during thyroid-stimulating hormone (TSH) stimulation. However, temporary discontinuation of therapy increase TSH (withdra...

Recombinant human thyroid-stimulating hormone (rhTSH) was approved for diagnostic testing by the U.S. Food and Drug Administration in November 1998. It has subsequently been approved in Europe and Australia and is available in many other countries on a restricted basis. Approval was based on its ability to stimulate the uptake of radioiodine into thyroid remnants and metastases of thyroid cance...